Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Total Valuation
Resmed has a market cap or net worth of $36.00B. The enterprise value is $35.84B.
Market Cap$36.00B
Enterprise Value$35.84B
Share Statistics
Resmed has 146,627,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding146,627,400
Owned by Insiders0.52%
Owned by Institutions9.97%
Financial Efficiency
Resmed’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.69%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)17.69%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee469.47K
Profits Per Employee102.30K
Employee Count9,980
Asset Turnover0.68
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of Resmed is 26.92. Resmed’s PEG ratio is 5.22.
PE Ratio26.92
PS Ratio0.00
PB Ratio6.48
Price to Fair Value5.65
Price to FCF22.97
Price to Operating Cash Flow21.75
PEG Ratio5.22
Income Statement
In the last 12 months, Resmed had revenue of 4.69B and earned 1.02B in profits. Earnings per share was 6.94.
Revenue4.69B
Gross Profit2.66B
Operating Income1.32B
Pretax Income1.26B
Net Income1.02B
EBITDA1.53B
Earnings Per Share (EPS)6.94
Cash Flow
In the last 12 months, operating cash flow was 1.65B and capital expenditures -88.59M, giving a free cash flow of 1.56B billion.
Operating Cash Flow1.65B
Free Cash Flow1.56B
Free Cash Flow per Share10.67
Dividends & Yields
Resmed pays an annual dividend of $0.529, resulting in a dividend yield of 0.84%
Dividend Per Share$0.529
Dividend Yield0.84%
Payout Ratio23.30%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.10
52-Week Price Change14.89%
50-Day Moving Average228.23
200-Day Moving Average234.92
Relative Strength Index (RSI)55.37
Average Volume (3m)1.13M
Important Dates
Resmed upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 23, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateMay 08, 2025
Financial Position
Resmed as a current ratio of 2.59, with Debt / Equity ratio of 15.14%
Current Ratio2.59
Quick Ratio1.69
Debt to Market Cap0.03
Net Debt to EBITDA0.41
Interest Coverage Ratio28.88
Taxes
In the past 12 months, Resmed has paid 243.85M in taxes.
Income Tax243.85M
Effective Tax Rate0.19
Enterprise Valuation
Resmed EV to EBITDA ratio is 18.34, with an EV/FCF ratio of 21.86.
EV to Sales6.00
EV to EBITDA18.34
EV to Free Cash Flow21.86
EV to Operating Cash Flow20.07
Balance Sheet
Resmed has $932.71M in cash and marketable securities with $839.77M in debt, giving a net cash position of -$92.94M billion.
Cash & Marketable Securities$932.71M
Total Debt$839.77M
Net Cash-$92.94M
Net Cash Per Share-$0.63
Tangible Book Value Per Share$10.45
Margins
Gross margin is 58.53%, with operating margin of 28.17%, and net profit margin of 21.79%.
Gross Margin58.53%
Operating Margin28.17%
Pretax Margin27.00%
Net Profit Margin21.79%
EBITDA Margin32.73%
EBIT Margin27.97%
Analyst Forecast
The average price target for Resmed is $265.11, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$265.11
Price Target Upside9.17% Upside
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast9.54%
EPS Growth Forecast37.23%